Cao, Z., Sui, E. and Wu, Y. (2022) “Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies”, BCP Business & Management, 31, pp. 378–391. doi:10.54691/bcpbm.v31i.2653.